US-based nuclear technology company Shine Medical Technologies has selected the municipality of Veendam in the province of Groningen, the Netherlands, for its European medical isotope production facility.
Construction of the facility is expected to begin in 2023 with commercial production scheduled to begin in late 2025. Shine said the facility will be driven by nuclear fusion technology that does not require a nuclear reactor.
The Wisconsin company said the decision is the culmination of a year-long search process that included the review of more than 50 proposals from sites across Europe.
Construction of the facility is expected to begin in 2023 with commercial production scheduled to begin in late 2025. Shine said the facility will be driven by nuclear fusion technology that does not require a nuclear reactor.
The Wisconsin company said the decision is the culmination of a year-long search process that included the review of more than 50 proposals from sites across Europe.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
